Disappointing Trial Results For EnteroMedics By: MarketMinute.com Stock News October 02, 2009 at 13:24 PM EDT Shares of EnteroMedics Inc. (Nasdaq: ETRM) collapsed $3.25 to $1.23 after the company reported disappointing preliminary results for obesity treatment.